To determine the signs of cross-regulatory connections between ERα and GATA3, we used siRNA to decrease either ERα or GATA3 protein synthesis and then examined the change in ERα and GATA3 protein levels in the ERα–positive T47D breast cancer cell line. The gene discussed is GATA3; the disease is breast cancer.